TY - JOUR
T1 - Dissociation of relaxin and progesterone secretion from the primate corpus luteum by acute administration of a 3β-hydroxysteroid dehydrogenase inhibitor during the menstrual cycle
AU - Duffy, D. M.
AU - Stouffer, R. L.
AU - Stewart, D. R.
N1 - Copyright:
Copyright 2007 Elsevier B.V., All rights reserved.
PY - 1995
Y1 - 1995
N2 - The factors regulating relaxin production by the primate CL during spontaneous menstrual cycles and in early pregnancy are poorly understood. Since the CL produces steroids, notably progesterone, and expresses progesterone receptors, luteal progesterone may act locally to regulate relaxin production. For the current study, either trilostane (600 mg daily)- a 3β-hydroxysteroid dehydrogenase inhibitor-or vehicle was administered to rhesus monkeys during the midluteal phase (Days 6 and 7) of spontaneous menstrual cycles to examine the effects of reduced luteal progesterone synthesis on relaxin secretion. Trilostane treatment reduced serum concentrations of progesterone within 3 h of initial administration and maintained low levels typical of the follicular phase (< 1 ng/ml), causing premature manses without significant alteration in serum bioactive LH levels. Nevertheless, the patterns and levels of circulating relaxin, as measured by homologous macaque ELISA, were not different between trilostane- and vehicle- treated monkeys, with relaxin levels peaking in both groups by Day 13 of the luteal phase. To determine if chorionic gonadotropin (CG) injections simulating early pregnancy could stimulate relaxin production in a progesterone-depleted environment, trilostane or vehicle was administered as described above, followed by injections in increasing dosages of human (h) CG beginning 3 days after initial trilostane administration. Serum progesterone levels in trilostane-treated animals were significantly reduced prior to and during hCG treatment when compared with vehicle-treated animals. However, serum relaxin levels were comparable between these groups; relaxin levels peaked approximately 10-fold above pre-hCG levels in both trilostane- and vehicle-treated animals. These data indicate that serum relaxin levels similar to those observed in control monkeys can be maintained during a period of very low progesterone concentrations during the spontaneous menstrual cycle and that even in a progesterone-depleted environment, CG remains an effective stimulator of relaxin production. Therefore, it is unlikely that progesterone acts locally to promote the production and release of relaxin from the primate CL during the menstrual cycle or early pregnancy.
AB - The factors regulating relaxin production by the primate CL during spontaneous menstrual cycles and in early pregnancy are poorly understood. Since the CL produces steroids, notably progesterone, and expresses progesterone receptors, luteal progesterone may act locally to regulate relaxin production. For the current study, either trilostane (600 mg daily)- a 3β-hydroxysteroid dehydrogenase inhibitor-or vehicle was administered to rhesus monkeys during the midluteal phase (Days 6 and 7) of spontaneous menstrual cycles to examine the effects of reduced luteal progesterone synthesis on relaxin secretion. Trilostane treatment reduced serum concentrations of progesterone within 3 h of initial administration and maintained low levels typical of the follicular phase (< 1 ng/ml), causing premature manses without significant alteration in serum bioactive LH levels. Nevertheless, the patterns and levels of circulating relaxin, as measured by homologous macaque ELISA, were not different between trilostane- and vehicle- treated monkeys, with relaxin levels peaking in both groups by Day 13 of the luteal phase. To determine if chorionic gonadotropin (CG) injections simulating early pregnancy could stimulate relaxin production in a progesterone-depleted environment, trilostane or vehicle was administered as described above, followed by injections in increasing dosages of human (h) CG beginning 3 days after initial trilostane administration. Serum progesterone levels in trilostane-treated animals were significantly reduced prior to and during hCG treatment when compared with vehicle-treated animals. However, serum relaxin levels were comparable between these groups; relaxin levels peaked approximately 10-fold above pre-hCG levels in both trilostane- and vehicle-treated animals. These data indicate that serum relaxin levels similar to those observed in control monkeys can be maintained during a period of very low progesterone concentrations during the spontaneous menstrual cycle and that even in a progesterone-depleted environment, CG remains an effective stimulator of relaxin production. Therefore, it is unlikely that progesterone acts locally to promote the production and release of relaxin from the primate CL during the menstrual cycle or early pregnancy.
UR - http://www.scopus.com/inward/record.url?scp=0029150139&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029150139&partnerID=8YFLogxK
U2 - 10.1095/biolreprod53.2.447
DO - 10.1095/biolreprod53.2.447
M3 - Article
C2 - 7492699
AN - SCOPUS:0029150139
SN - 0006-3363
VL - 53
SP - 447
EP - 453
JO - Biology of Reproduction
JF - Biology of Reproduction
IS - 2
ER -